Increasing the clinical efficacy of NK and antibody-mediated cancer immunotherapy: Potential predictors of successful clinical outcome based on observations in high-risk neuroblastoma
Tony A. Koehn, Lori L. Trimble, Kory L. Alderson, Amy K. Erbe, Kimberly A. McDowell, Bartosz Grzywacz, Jacquelyn A. Hank, Paul M. Sondel
Dive into the research topics of 'Increasing the clinical efficacy of NK and antibody-mediated cancer immunotherapy: Potential predictors of successful clinical outcome based on observations in high-risk neuroblastoma'. Together they form a unique fingerprint.